5LO Cancer Research Results
5LO, 5-lipoxygenase (5-LO): Click to Expand ⟱
| Source: |
| Type: |
5‑Lipoxygenase (5‑LO) is an enzyme that catalyzes the oxygenation of arachidonic acid to produce leukotrienes and other bioactive lipid mediators. It is a member of the lipoxygenase family and plays a key role in inflammatory responses.
5‑LO is overexpressed in various malignancies, particularly those with a strong inflammatory component.
Overexpression of 5‑LO is often detected in tumor cells as well as in stromal cells (e.g., tumor-associated macrophages) within the tumor microenvironment.
Elevated 5‑LO expression is frequently linked with increased tumor proliferation, enhanced angiogenesis, and higher metastatic potential—factors that often correlate with a poor prognosis.
|
Scientific Papers found: Click to Expand⟱
*antiOx↑, its role as health-promoting effect is attributed because it is rich source of antioxidant.
P53↑, anticancer management through the modulation of various molecular pathways including p53, pTEN, NF-κB, PI3K/Akt, Bcl-2, and VEGF
PTEN↑, figure 2
NF-kB↓,
PI3K↓,
Akt↓,
Bcl-2↓,
VEGF↓,
*Inflam↓, Neem also plays role as anti-inflammatory via regulation of proinflammatory enzyme activities including cyclooxygenase (COX), and lipoxygenase (LOX) enzyme.
*COX2↓,
*5LO↝,
*Wound Healing↑, figure 1
*Imm↑,
*hepatoP↑,
*AntiDiabetic↑,
*neuroP↑,
*AntiViral↑,
*Bacteria↑,
*AntiBio↑,
*AntiFungal↑,
cMyc↓, figure 2
BAX↓,
IAP1↓, Nimbolide downregulated cell survival proteins, including I-FLICE, cIAP-1, cIAP-2, Bcl-2, Bcl-xL, survivin, and X-linked inhibitor of apoptosis protein, and upregulated the proapoptotic proteins p53 and Bax
IAP2↓,
Bcl-xL↓,
survivin↓,
XIAP↓,
angioG↓, ethanolic fraction of neem leaf (EFNL) treatment effectively inhibited the expression of proangiogenic genes,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics(tgid=3) ⓘ
XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, BAX↓, 1, Bcl-2↓, 1, Bcl-xL↓, 1, IAP1↓, 1, IAP2↓, 1, survivin↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, PTEN↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Total Targets: 15
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Migration(tgid=13) ⓘ
5LO↝, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, Imm↑, 1, Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, hepatoP↑, 1, neuroP↑, 1, Wound Healing↑, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiFungal↑, 1, AntiViral↑, 1, Bacteria↑, 1,
Total Targets: 13
Scientific Paper Hit Count for: 5LO, 5-lipoxygenase (5-LO)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1090 State#:% Dir#:4
wNotes=on sortOrder:rid,rpid
Home Page